News

The facility in Nansha operates two small scale trains supplying clinical material, three large scale API trains for metric tons, and cGMP laboratories to meet gram-scale demands. The

As per the terms of the collaboration, Novozymes receives non-exclusive license to use MorphoSys’s Slonomics technology to develop novel products within the industrial biotechnology sector. The Advanced Protein

Enlight emphasizes on areas including molecular imaging, biologics, drug formulation delivery methods, besides novel chemistries, production technologies, biomarkers and drug safety. Enlight CEO Michelle Browner said the company

The FDA has also granted the company’s request for six-month Priority Review of Kalydeco, acts by targeting the defective protein that causes CF. The move follows the results

In July 2010, Servier and Galapagos collaborated to develop new medicines for the treatment of osteoarthritis (OA). Galapagos is responsible for the discovery and development of new candidate

Belimumab belongs to a class of drugs known as BLyS-specific inhibitors. The multi-center, international, randomized, double-blind, placebo-controlled, 52-week study will investigate use of belimumab administered subcutaneously (SC) once-weekly

Both the companies entered into the collaboration in December 2010 under which Phylogica has identified various peptides from its Phylomer libraries that will be further evaluated for their

Gilenya, licensed from Mitsubishi Tanabe Pharma is the first in a new class of compounds called sphingosine 1-phosphate receptor (S1PR) modulators. The two-year placebo-controlled parallel-group multi-centre Phase III

Shape memory polymers are made of advanced materials which can remember more many shapes and can transit easily between those shapes with minimal force and without loss of